Express News | Voyager Therapeutics : Candidate Vy1706 Demonstrates Significant Reductions of Tau at Low Doses in Nhp Study; Ind & Cta Filings Anticipated in 2026

BreakingsNov 20 20:02

Express News | Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

BreakingsNov 20 20:02

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease

GlobeNewswireNov 20 20:00

Not Many Are Piling Into Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Yet As It Plummets 29%

Simply Wall StNov 16 20:18

Voyager Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 15 00:24 · Ratings

Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

BenzingaNov 14 22:00